1. Introduction {#sec1}
===============

Viral skin infections (VSIs) were ranked among the top 50 prevalent diseases in 2010 with a global prevalence of 122,601,000 \[[@B1]\]. Common VSIs include herpes simplex (HS), herpes zoster (HZ), molluscum contagiosum (MC), anogenital warts, and viral warts \[[@B2]\]. Geographically representative data, on the periodic evaluation of epidemiology of VSIs, are important from clinical and public health perspectives. The objective of this study was to determine the epidemiologic features of VSIs in a cohort of patients attending a dermatology clinic in Egypt.

2. Patients and Methods {#sec2}
=======================

The study was approved by the Institutional Research and Ethical Committees, Faculty of Medicine, Sohag University, Egypt. This cross-sectional study included patients who attended a dermatology clinic at Sohag University Hospitals, a tertiary care medical facility in Upper Egypt, between June 2010 and May 2011, and were diagnosed as having VSIs. Patients from all age groups and both sexes were included. Patient\'s residence, occupation, housing data (number of persons per room), and family history of similar conditions were obtained from the participants. Dermatological examination was conducted by a senior dermatology resident and was verified by a dermatology consultant.

The classification and clinical diagnosis of VSIs were made following the tenth edition of the International Statistical Classification of Diseases (ICD-10) \[[@B3]\] and the eighth edition of Rook\'s Text Book of Dermatology \[[@B4]\], respectively. Accordingly, VSIs were listed as viral warts (verrucae), anogenital (venereal) warts, HS facialis, chickenpox (CP), HZ, and MC \[[@B3]\]. Categorical data were recorded as frequencies and percentages and were compared by Chi square test. Level of significance was considered at p value \< 0.05.

3. Results {#sec3}
==========

In this study, clinical diagnosis of VSIs was made in 1000/20322 (4.9%) patients who attended a dermatology clinic over a period of one year. Out of the 1000 patients with VSIs, 580 (58.0%) were residents of rural areas and 420 (42.0%) were residents of urban areas (p = 0.02). Out of the 1000 patients, 489 (48.9%) were females and 511 (51.1%) were males (p = 0.25).

The clinical patterns, frequencies, and percentages of VSIs, at different age groups and in both sexes, are shown in [Table 1](#tab1){ref-type="table"}. The breakdown of the 673 patients with viral warts indicated a clinical diagnosis of common warts in 302 (44.9%), plantar warts in 267 (39.8%), plane warts in 38 (5.8%), filiform warts in 17 (2.5%), and mixed varieties (more than one type of viral warts) in 47 patients (7.0%). Out of the 673 patients diagnosed with viral warts, 189 (28.1%) were students, 172 (25.6%) were manual workers, and 106 (15.8%) were housewives.

Family history of a similar condition was positive in 329/1000 (32.9%) of the patients with VSIs \[142/200 (71.0%) of the patients with CP, 177/673 (26.3%) of the patients with viral warts, 5/27 (18.5%) of the patients with MC, and 4/50 (8%) of the patients with HS facialis\]. Overcrowding (sharing a bedroom by more than 3 persons) was recorded in 652/1000 (65.2%) of the patients with VSIs \[165/200 (82.5.3%) of the cases with CP, 36/50 (72%) of the cases with HS facials, 427/673 (63.4%) of the cases with viral warts, 14/27 (51.9%) of the cases with MC, and 10/42 (23.8%) of the cases with HZ\].

4. Discussion {#sec4}
=============

Viral skin infections account for a significant portion of dermatologic diseases, often resulting in, or as a consequence of, a disruption in the skin integrity \[[@B2]\]. Previous studies on VSIs were directed towards investigating the epidemiologic and clinical features of selected varieties of viruses such as human papilloma virus \[[@B5], [@B6]\] or HS virus type 2 \[[@B7]--[@B9]\]. Other studies were aimed at examining the role of cutaneous viral infections in the pathogenesis of skin and extracutaneous cancers \[[@B10], [@B11]\]. However, data on the global epidemiologic aspects of VSIs are lacking. In this study, VSIs were diagnosed in 4.9% of all patients who attended an outpatient dermatology clinic in Upper Egypt and were more frequently seen among rural residents. In previous epidemiological studies of skin diseases, using hospital-based data, the rate of VSIs was 7.35% in Cairo, Egypt \[[@B12]\], 6.1% in Nigeria \[[@B13]\], 6.4% in Iran \[[@B14]\], and 12.8% in Saudi Arabia \[[@B15]\].

Viral warts were the commonest VSIs, observed in this study, and accounted for approximately 2/3 of all cases. Similarly, viral warts accounted for high proportions of VSIs in previous studies from Cairo, Egypt (75.05%) \[[@B12]\], Nigeria (40.4%) \[[@B13]\], Iran (55.1%) \[[@B14]\], and Saudi Arabia (65.64%) \[[@B15]\]. In this study, common warts and plantar warts were the commonest varieties of viral warts and represented more than 3/4 of all cases. Viral warts were more prevalent among students, manual workers, and housewives and in overcrowded conditions. Increased potential for minor trauma, in manual worker and housewives, and overcrowding may play a role in the transmission of viral warts in those selected categories of patients.

Chickenpox accounted for 1/5 of VSIs, in this study, and was more prevalent among children. Overcrowding and positive family history were recorded in the majority of CP cases included in the current study. Crowded conditions may facilitate direct or indirect transmission of CP among those patients. In previous reports on VSIs, the rate of CP was 6.69% in Cairo, Egypt \[[@B12]\], 10.9% in Iran \[[@B14]\], and 12.8% in Saudi Arabia \[[@B15]\]. Less common types of VSIs, recorded in this study, included HS facialis, HZ, MC, and anogenital warts.

The data emerging from the current study highlighted some epidemiological aspects of VSIs among patients living in Upper Egypt. The rate of VSIs (4.9%), in this study, was lower as compared to the rate of 7.35% reported in a previous national study conducted in Cairo \[[@B12]\]. In both studies, viral warts represented high proportions of VSIs while the rate of CP was lower in the previous study from Cairo (6.69% vs 20.0%). The retrospective nature of the previous study that was conducted in Cairo and inclusion of the majority of patients from urban areas may explain, at least in part, the discrepancies noted in the results of the two studies.

On the other hand, the variation in the epidemiology of VSIs, in this study, from previous international reports \[[@B13]--[@B15]\], may be related to factors such as differences in environmental factors, socioeconomic conditions, and changes in the virulence of the cutaneous viral pathogens. Other suggested reasons for disparity in the prevalence of skin diseases globally may include differences in the type of reported prevalence, study methodology, geographic areas, ethnic groups, and age distribution \[[@B16]\]. Continuous and sustainable national and local data collection have been recommended to reduce the burden of disease in developing countries and narrow the health gap between the developed and developing worlds \[[@B17]\].

Despite interesting findings of this study, few limitations were noted. First, the lack of laboratory tests such as polymerase chain reaction or culture precluded us from identification of specific viral species responsible for VSIs. Second, the hospital-based design precluded us from evaluation of the true prevalence of VSIs in the community.

Third, the finding of low rates of genital warts and anogenital herpes viral infections may not be accurate as patients may prefer to attend private clinics or be seen by gynecologists or urologists. Similarly, the rates of CP and MC, recorded in this study, may be underestimated as a considerable proportion of those patients may consult pediatricians rather than dermatologists. Future community-based studies including laboratory tests, for viral identification, may help overcome these shortcomings and provide accurate estimates for the epidemiology of VSIs.

5. Conclusion {#sec5}
=============

In this study, viral warts and CP were the commonest varieties of VSIs diagnosed in patients who attended a dermatology clinic in Egypt. Viral skin infections were more prevalent among patients who lived in rural areas and under crowded conditions. These data may have important public health implications particularly in the developing countries. Healthcare strategies directed towards improving the socioenvironmental factors, in those countries, may play a role in the prevention and control of VSIs.
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###### 

The clinical patterns, frequencies, and percentages of viral skin infections at different age groups and in both sexes (total number = 1000).

  **Clinical pattern**               **Age group**   **Total number (**%**)**                                        
  ---------------------------------- --------------- -------------------------- ------------ ----------- ----------- ----------------
  Viral warts (*∗*B07)               61              164                        358          76          14          **673 (67.3)**
  Female                                                                                                             **323 (32.3)**
  Male                                                                                                               **350 (35.0)**
                                                                                                                     
  Chickenpox (*∗*B01)                150             46                         4            0           0           **200 (20.0)**
  Female                                                                                                             **87 (8.7)**
  Male                                                                                                               **113 (11.3)**
                                                                                                                     
  Herpes simplex facialis (B0)       15              8                          23           4           0           **50 (5.0)**
  Female                                                                                                             **37 (3.7)**
  Male                                                                                                               **13 (1.3)**
                                                                                                                     
  Herpes zoster (*∗*B02)             1               5                          3            13          20          **42 (4.2)**
  Female                                                                                                             **22 (2.2)**
  Male                                                                                                               **20 (2.0)**
                                                                                                                     
  Molluscum contagiosum (*∗*B08.1)   11              5                          7            4           0           **27 (2.7)**
  Female                                                                                                             **19 (1.9**
  Male                                                                                                               **8 (0.8)**
                                                                                                                     
  Anogenital warts (*∗*A63.0)                                                   7            1                       **8 (0.8)**
  Female                                                                                                             **1 (0.1)**
  Male                                                                                                               **7 (0.7)**
                                                                                                                     
  **Total number (**%**)**           **238**         **228**                    **402**      **98**      **34**      **1000**
                                     **(23.8)**      **(22.8)**                 **(40.2)**   **(9.8)**   **(3.4)**   **(**100%**)**

*∗* means ICD-10: International Statistical Classification of Diseases, version 10.
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